| Sensitivity (95% CI) | Specificity (95% CI) | Positive predictive value (95% CI) | Negative predictive value (95% CI) |
---|---|---|---|---|
Meets at least one BLEED criterion | Â | Â | Â | Â |
   Development, n = 96 (51%) | 0.83 (0.67, 0.98) | 0.53 (0.46, 0.61) | 0.20 (0.12, 0.28) | 0.96 (0.91, 1.0) |
   Validation, n = 84 (63%) | 0.77 (0.60, 0.95) | 0.39 (0.30, 0.48) | 0.20 (0.12, 0.29) | 0.90 (0.81, 0.98) |
Red blood or unstable comorbidity or elevated prothrombin time | Â | Â | Â | Â |
   Development, n = 71 (40%) | 0.74 (0.56, 0.92) | 0.65 (0.57, 0.92) | 0.24 (0.14, 0.34) | 0.94 (0.90, 0.99) |
   Validation, n = 71 (55%) | 0.73 (0.62, 0.82) | 0.48 (0.43, 0.53) | 0.23 (0.17, 0.27) | 0.89 (0.85, 0.94) |
Red blood or unstable comorbidity | Â | Â | Â | Â |
   Development, n = 63 (34%) | 0.70 (0.51, 0.88) | 0.71 (0.64, 0.78) | 0.25 (0.15, 0.36) | 0.94 (0.90, 0.98) |
   Validation, n = 66 (50%) | 0.73 (0.54, 0.91) | 0.55 (0.45, 0.64) | 0.24 (0.14, 0.35) | 0.91 (0.84, 0.98) |